ABSTRACT
During recent years, we have treated a large number of patients (more than 200) with various autoimmune conditions using intravenous immunoglobulin (IVIG). This chapter reviews our experience with IVIG treatment in fibrotic conditions, and describes our findings and experience regarding the effect of IVIG therapy to prevent metastases in malignancy.
